It's a contrast of view on what should be a very good company with great tech that is being mismanaged.
There are other similar Aussie life science stocks that have contrasting management and strategies and the share price is reflecting this
Ann: Change of Director's Interest Notice - M Perry, page-9
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.02 |
Change
-0.080(2.58%) |
Mkt cap ! $212.9M | |||
| Open | High | Low | Value | Volume |
| $3.09 | $3.11 | $3.00 | $438.3K | 144.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3373 | $3.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.04 | 69 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |